Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Vion Pharmaceuticals)"
Count: 23
Selected: 0
NCT IDTitle
NCT00354276VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia
NCT00304005VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders
NCT00282022VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer
NCT00112554Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia
NCT00098436Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
NCT00083187VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
NCT00070538VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
NCT000640903-AP and Cytarabine in Treating Patients With Hematologic Cancer
NCT000640643-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer
NCT000640513-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
NCT000540153-AP in Treating Patients With Advanced Prostate Cancer
NCT00049699VNP40101M in Treating Patients With Advanced or Metastatic Cancer
NCT00049686VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
NCT00025129VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas
NCT00024323Combination Chemotherapy in Treating Patients With Advanced Cancer
NCT000168743-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer
NCT00006254VNP20009 in Treating Patients With Advanced Solid Tumors
NCT000062183-AP in Treating Patients With Advanced Cancer
NCT00004216VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy
NCT000042133-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
NCT00655395Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine
NCT00521859Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
NCT00516282VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma